Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
CD8A VHH recombinant monoclonal antibody
CD96 VHH recombinant monoclonal antibody
CDH6 VHH recombinant monoclonal antibody
CEA VHH recombinant monoclonal antibody
CEACAM6 VHH recombinant monoclonal antibody
CFD VHH recombinant monoclonal antibody
CFP VHH recombinant monoclonal antibody
Claudin-18 VHH recombinant monoclonal antibody
Claudin-18.2 VHH recombinant monoclonal antibody
CLDN1 VHH recombinant monoclonal antibody
CLEC12A VHH recombinant monoclonal antibody
CLEC4C VHH recombinant monoclonal antibody